Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ex vivo susceptibilities to ganaplacide and diversity in potential resistance mediators in Ugandan Plasmodium falciparum isolates

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.00466-24Source: DataRank Database

Ex vivo susceptibilities to ganaplacide and diversity in potential resistance mediators in Ugandan Plasmodium falciparum isolates is a research paper published in Antimicrobial Agents and Chemotherapy (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.42)OA: greenTopics (54)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Stephen Orena,Martin Okitwi ORCID,Patrick K. Tumwebaze ORCID,Oswald Byaruhanga,Thomas Katairo ORCID

Live enrichment

PubMed:39136468 PMC:PMC11373204 OpenAlex:https://openalex.org/W4401546846

HHS | NIH | OSC | Common Fund

Grant: R01AI139179

HHS | NIH | OSC | Common Fund

Grant: R01AI075045

Medicines for Malaria Venture

Grant: RD/15/0001

National Institutes of Health

Grant: 2R01AI075045-11A1

Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies in Uganda

National Institutes of Health

Grant: 5R01AI139179-07

Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline

FWCI

0.42

Citation Percentile

0.7%

Citation Trend

2025

greenLicense: https://doi.org/10.1128/ASMCopyrightv2

repositoryhttps://escholarship.org/content/qt3mr886bk/qt3mr886bk.pdf

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.00466-24

repositoryhttps://escholarship.org/uc/item/3mr886bk

journalhttps://doi.org/10.1128/aac.00466-24

Fields of Study

Malaria Research and ControlComputational Drug Discovery MethodsHIV/AIDS drug development and treatment0301 basic medicine0303 health sciences03 medical and health sciencesPlasmodium falciparumAntimalarialsUgandaHumansDrug ResistanceMalaria, FalciparumProtozoan ProteinsInhibitory Concentration 50PiperazinesParasitic Sensitivity Tests

MeSH Terms

AntimalarialsDrug ResistanceHumansPiperazinesPlasmodium falciparumUgandaProtozoan ProteinsMalaria, FalciparumInhibitory Concentration 50Parasitic Sensitivity Tests

Keywords

Plasmodium falciparumBiologyGenotypeDrug resistanceLocus (genetics)GeneticsMicrobiologyVirologyGeneMalariaImmunologyAntimalarial DrugsDrug SusceptibilityPfcarlGanaplacidePfugtPfactFalciparum570Protozoan Proteins610PiperazinesAntimalarialsInhibitory Concentration 50Parasitic Sensitivity TestsHumansUgandaMalaria, Falciparum

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being